Drug Product
Company Overview
About
Arevipharma GmbH is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:Germany
Founded:2019
Employees:201
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
Asia-Pacific
Manufacturing Facilities
1 site worldwide
Arevipharma GmbH
Meisner Str 35, Radebeul, 01445
Site Capabilities
1 capabilityAPI MANUFACTURE
International Regulatory
EU GMP Certificates
8
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval CKCEYS
Health Canada · #APR-BDA4G2C5 · 2020-01-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-FSRMQ4OJ
Issued: 2020-11-08
Expires: 2025-09-02
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-CNWP6WU3
Issued: 2020-02-17
Expires: 2025-04-01
WHO GMP
World Health Organization
Cert #: CERT-BICZVOZH
Issued: 2020-09-04
Expires: 2025-01-07
Health Canada GMP
Health Canada
Cert #: CERT-VOKJZ2K2
Issued: 2020-01-04
Expires: 2025-03-02
Loading CDMO intelligence...
Key facts about Arevipharma GmbH
- Arevipharma GmbH is headquartered in Germany.
- Arevipharma GmbH was founded in 2019.
- Arevipharma GmbH has 201 employees.
- Arevipharma GmbH has one manufacturing site listed on CDMO Hub, in Radebeul, Germany.
- Arevipharma GmbH's capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like Arevipharma GmbH
Directory pages this company appears in, each with the full list of matching manufacturers.